Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2025-12-25 @ 8:50 PM
Study NCT ID:
NCT03560856
Status:
UNKNOWN
Last Update Posted:
2018-06-18
First Post:
2018-06-01
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Biomarker Study of Palbociclib + Fulvestrant for Second, and Third Line of Postmenopausal Women With hr+/her2- Advanced Breast Cancer
Sponsor:
Assistance Publique - Hôpitaux de Paris
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-06-27
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-06-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-06-01
Completion Date Type:
ESTIMATED
First Submit Date:
2018-06-01
First Submit QC Date:
None
Study First Post Date:
2018-06-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-06-15
Last Update Post Date:
2018-06-18
Last Update Post Date Type:
ACTUAL